OVID financials
Ovid Therapeutics (OVID) financials: revenue, profit and margins by year and quarter, the balance sheet and cash flow.
OVID income statement, yearly
| Year | Revenue | Gross profit | Operating income | Net income | EPS |
|---|---|---|---|---|---|
| 2025 | $7.25M | $6.95M | -$42.44M | -$17.41M | -0.24 |
| 2024 | $566.00K | $566.00K | -$61.88M | -$26.43M | -0.37 |
| 2023 | $392.00K | $392.00K | -$59.28M | -$52.34M | -0.74 |
| 2022 | $1.50M | $1.50M | -$55.55M | -$54.17M | -0.77 |
| 2021 | $208.38M | $208.38M | $124.21M | $122.83M | 1.76 |
| 2020 | $12.62M | $12.62M | -$81.43M | -$81.04M | -1.39 |
- OVID revenue was $7.25M in fiscal 2025, net income -$17.41M.
Updated 2026-11-07 11:54 UTC